Wider window for stroke drug

Stroke patients can benefit from treatment with alteplase even if they miss the drug's three-hour treatment window, research suggests.

But fast treatment remains patients' best hope of achieving recovery, researchers stressed.

The thrombolytic drug alteplase is currently licensed for use within three hours of an acute ischaemic stroke.

Researchers from the University of Heidelberg, Germany, looked at benefits for patients outside this window.

They randomised 821 patients presenting between three and 4.5 hours after onset of stroke to receive alteplase or placebo.

All endpoints studied showed benefits for a wide range of patients, but not all differences were statistically significant.

'Our results support the use of this thrombolytic drug in the extended period across a broad range of patient subgroups,' the researchers said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Hospitals adding to GP crisis with constant flow of work dumped on practices, say LMCs

Hospitals adding to GP crisis with constant flow of work dumped on practices, say LMCs

Hospitals are compounding the GP workload crisis by dumping 'endless tasks' on primary...

Abnormal vaginal discharge - red flag symptoms

Abnormal vaginal discharge - red flag symptoms

Advice on red flag symptoms in patients with vaginal discharge, including what examinations...

GMC demands 'greater autonomy' to tackle bias against BAME doctors

GMC demands 'greater autonomy' to tackle bias against BAME doctors

The GMC has called for ‘greater autonomy’ to choose the complaints it investigates,...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Government must invest to end 'historic' GP crisis in wake of COVID-19, says BMA

Government must invest to end 'historic' GP crisis in wake of COVID-19, says BMA

General practice is facing 'historic workforce and workload crises' that have been...

Most GP care should be face-to-face post-COVID, says RCGP

Most GP care should be face-to-face post-COVID, says RCGP

General practice faces a 'rebalancing' between face-to-face and remote consultations...